Free subscription to the Capitol Journal keeps you current on legislative and regulatory news.
States Continue to Target AI-Driven Rental Pricing Nineteen states are considering bills that would limit the use of third-party software relying on competitor data to set rental housing prices, according...
Trump, Congress Weigh Measures to Preempt State AI Laws The Trump administration circulated—and then put on hold—a draft executive order aimed at preempting state laws regulating artificial...
Last year, after Colorado and California became the first states in the nation to expand privacy protections to include neural data, we said more states could follow suit . This year two more have done...
MI Lawmakers Advance Medical Debt Protections The Michigan Senate’s Health Policy Committee has advanced a trio of bipartisan bills aimed at reducing the burden of medical costs on residents of...
EU Reversing Course on Tech Regulation After aggressively regulating the technology industry for over a decade, the European Union is moving to loosen its landmark digital privacy and artificial intelligence...
* The views expressed in externally authored materials linked or published on this site do not necessarily reflect the views of LexisNexis Legal & Professional.
On Oct. 3 Colorado’s Prescription Drug Affordability Review Board set an upper payment limit, or UPL, for Enbrel, a prescription drug used to treat rheumatoid arthritis and other autoimmune diseases. The cap—limiting what insurers and patients pay for the medication to no more than about $31,000 per year, nearly half the $53,049 average amount insurance plans paid for the drug in 2023—is the first such limit to be imposed in the nation. (COLORADO SUN)
—Compiled by SNCJ Managing Editor KOREY CLARK
Visit our webpage to connect with a LexisNexis® State Net® representative and learn how the State Net legislative and regulatory tracking service can help you identify, track, analyze and report on relevant legislative and regulatory developments.